Email Alert | RSS    帮助

中国防痨杂志 ›› 2026, Vol. 48 ›› Issue (7): 1000-1006.doi: 10.19982/j.issn.1000-6621.20260112

• 论著 • 上一篇    下一篇

基于CD4+ T淋巴细胞水平的结核病并发HIV/AIDS手术效果评价

刘爱梅1(), 刘桑1, 冯丽珍2, 王晴2   

  1. 1 广西壮族自治区胸科医院结核科, 柳州 545000
    2 广西壮族自治区胸科医院公共卫生科, 柳州 545000
  • 收稿日期:2026-03-05 出版日期:2026-07-10 发布日期:2026-07-02
  • 通信作者: 刘爱梅,Email:gxltyyliu@163.com
  • 基金资助:
    广西科技重大专项(桂科AA22096027);广西重点研发计划(桂科AB25069013)

Evaluation of surgical outcomes in tuberculosis complicated with HIV/AIDS based on CD4+ T lymphocyte levels

Liu Aimei1(), Liu Sang1, Feng Lizhen2, Wang Qing2   

  1. 1 Department of Tuberculosis, Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou 545000, China
    2 Department of Public Health, Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou 545000, China
  • Received:2026-03-05 Online:2026-07-10 Published:2026-07-02
  • Contact: Liu Aimei, Email: gxltyyliu@163.com
  • Supported by:
    Guangxi Major Science and Technology Project(Guike AA22096027);Guangxi Key R&D Program(Guike AB25069013)

摘要:

目的: 基于 CD4+ T淋巴细胞水平对接受外科手术治疗的结核病并发 HIV/AIDS 患者的临床指标进行系统评价,分析其术后长期随访的临床及免疫学指标变化,探索该类患者手术治疗效果与预后的影响因素。方法: 回顾性收集 2017 年 1 月至 2023 年 1 月在广西壮族自治区胸科医院接受外科手术治疗的 59 例结核病并发 HIV/AIDS 患者的病历资料。根据术前 CD4+ T淋巴细胞计数将研究对象分为观察组(CD4+ T淋巴细胞计数<200个/μl,41 例)和对照组(CD4+ T淋巴细胞计数≥200 个/μl,18 例)。收集并比较两组研究对象术前一般人口学特征、实验室检查指标,以及术后第7天、第14天、第12个月、第24个月的血常规、肝肾功能、免疫功能指标和切口愈合情况。结果: 观察组非结核病灶清除手术占比为90.24%(37/41),明显高于对照组的 66.67%(12/18);Ⅰ/Ⅱ级手术占比为 48.78%(20/41),明显高于对照组的 16.67%(3/18);Ⅰ类切口占比为70.73%(29/41),明显高于对照组的 27.78%(5/18),差异均有统计学意义(χ2值分别为4.940、5.423、11.763,P值均<0.05)。所有研究对象术前整体营养状况较差,血红蛋白异常率为71.19%(42/59),白蛋白异常率为66.10%(39/59)。术后 7d,研究对象切口愈合良好率为72.88%(43/59),其中,观察组为67.44%(29/43),对照组为32.56%(14/43);切口愈合不良率为27.12%(16/59),其中,观察组为75.00%(12/16),对照组为25.00%(4/16)。两组术后7d切口愈合情况差异无统计学意义(χ2=0.314,P=0.575)。术后 14d,仅4例研究对象仍存在切口愈合不良;术后 28d,所有研究对象切口均完全愈合,全程无机会性感染及并发症发生。术后不同随访时期,研究对象红细胞水平(${\chi }_{趋势}^{2}$=9.692,P=0.002)、白细胞水平(${\chi }_{趋势}^{2}$=17.307,P<0.001)、血红蛋白水平(${\chi }_{趋势}^{2}$=59.736,P<0.001)、血小板水平(${\chi }_{趋势}^{2}$=9.637,P<0.001)、天冬氨酸氨基转移酶水平(${\chi }_{趋势}^{2}$=12.320,P<0.001)、总胆红素水平(${\chi }_{趋势}^{2}$=5.494,P=0.019)、直接胆红素水平(${\chi }_{趋势}^{2}$=9.705,P=0.002)及白蛋白水平(${\chi }_{趋势}^{2}$=61.494,P<0.001)异常率均呈现明显线性下降趋势。结论: 接受外科手术治疗的结核病并发 HIV/AIDS患者的术后临床恢复情况与其营养状态、肝肾功能、切口愈合情况及免疫功能密切相关。CD4+ T淋巴细胞计数<200 个/μl并非该类患者外科手术的绝对禁忌证。对于拟行手术且CD4+ T淋巴细胞计数<200 个/μl的患者,应在传染病专家会诊指导下完成围手术期并发症的治疗,经综合评估后再实施手术。

关键词: 结核, HIV感染, 共病现象, 外科手术, T淋巴细胞

Abstract:

Objective: To systematically evaluate the clinical indicators of patients with tuberculosis complicated by HIV/AIDS undergoing surgical treatment based on CD4+ T lymphocyte levels, analyze the changes in clinical and immunological indicators during long-term postoperative follow-up, and explore the factors influencing surgical efficacy and prognosis in this population. Methods: A retrospective study was conducted to collect the medical records of 59 patients with tuberculosis complicated by HIV/AIDS who underwent surgical treatment at Guangxi Zhuang Autonomous Region Chest Hospital from January 2017 to January 2023. The subjects were divided into the observation group (CD4+ T lymphocyte count <200 cells/μl, n=41) and the control group (CD4+ T lymphocyte count ≥200 cells/μl, n=18) according to preoperative CD4+ T lymphocyte counts. Preoperative general demographic characteristics, laboratory test indicators, as well as blood routine, liver and kidney function, immune function indicators and incision healing status at postoperative day 7, day 14, month 12 and month 24 were collected and compared between the two groups. Results: The proportion of non-tuberculous focus debridement in the observation group was 90.24% (37/41), significantly higher than 66.67% (12/18) in the control group; the proportion of grade Ⅰ/Ⅱ surgeries was 48.78% (20/41), significantly higher than 16.67% (3/18) in the control group; and the proportion of class Ⅰ incisions was 70.73% (29/41), significantly higher than 27.78% (5/18) in the control group, with statistically significant differences (χ2=4.940, 5.423, 11.763, all P<0.05). All subjects had poor preoperative nutritional status, with an abnormal hemoglobin rate of 71.19% (42/59) and an abnormal albumin rate of 66.10% (39/59). At 7 days postoperatively, the good incision healing rate was 72.88% (43/59), including 67.44% (29/43) in the observation group and 32.56% (14/43) in the control group; the poor incision healing rate was 27.12% (16/59), including 75.00% (12/16) in the observation group and 25.00% (4/16) in the control group. There was no statistically significant difference in incision healing status between the two groups at 7 days postoperatively (χ2=0.314, P=0.575). At 14 days postoperatively, only 4 subjects still had poor incision healing; at 28 days postoperatively, all incisions were completely healed, and no opportunistic infections or complications occurred during the entire period. During different postoperative follow-up periods, the abnormal rates of red blood cell count (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=9.692, P=0.002), white blood cell count (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=17.307, P<0.001), hemoglobin level (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=59.736, P<0.001), platelet count (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=9.637, P<0.001), aspartate aminotransferase level (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=12.320, P<0.001), total bilirubin level (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=5.494, P=0.019), direct bilirubin level (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=9.705, P=0.002) and albumin level (${\chi }_{\mathrm{t}\mathrm{r}\mathrm{e}\mathrm{n}\mathrm{d}}^{2}$=61.494, P<0.001) all showed a significant linear downward trend. Conclusion: The postoperative clinical recovery of patients with tuberculosis complicated by HIV/AIDS undergoing surgical treatment is closely related to their nutritional status, liver and kidney function, incision healing status and immune function. CD4+ T lymphocyte count <200 cells/μl is not an absolute contraindication to surgical treatment in this population. For patients scheduled for surgery with CD4+ T lymphocyte count <200 cells/μl, perioperative complication management should be completed under the guidance of infectious disease specialists, and surgery should be performed after comprehensive evaluation.

Key words: Tuberculosis, HIV infections, Comorbidity, Surgical procedures, operative, T-lymphocytes

中图分类号: